AnX Robotica Unveils NaviCam XS, NaviCam XST, and ESView 3.0 at DDW 2025 to Exceptional Industry Response

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

PLANO, Texas, May 19, 2025 /PRNewswire/ — AnX Robotica, a leader in robotic capsule endoscopy and advanced GI diagnostics, proudly announced the successful launch of NaviCam XS, NaviCam XST, and ESView 3.0 during Digestive Disease Week (DDW) 2025. The unveiling drew exceptional interest, with clinicians, researchers, and industry professionals visiting the AnX Robotica booth to witness the next evolution in GI visualization technology.

AnX Robotica Showcases Breakthrough GI Technologies at DDW 2025

NaviCam XS, the latest addition to the NaviCam platform, introduces a capsule that is 44% smaller by volume than standard small bowel capsules, designed for enhanced patient comfort and easier ingestion without compromising on image quality or diagnostic reliability. This next-generation capsule further advances the possibilities of capsule endoscopy.

Alongside NaviCam XS, NaviCam XST made its debut, offering real-time esophageal visualization through a tethered capsule design. With ESView RT Display, clinicians can seamlessly navigate the esophagus without the need for sedation, providing an ideal solution for evaluating conditions such as reflux, and esophageal varices in real-time.

AnX Robotica also showcased ESView 3.0, the most advanced version of its software platform to date. With an intuitive interface, enhanced image clarity, and streamlined workflow, ESView 3.0 allows for faster interpretation, real-time annotation, and seamless report generation—enabling physicians to optimize diagnostic efficiency and patient outcomes.

“The response at DDW 2025 has been overwhelmingly positive,” said Stu Wildhorn, Vice President of Marketing and Product Management at AnX Robotica. “The enthusiasm from clinicians around NaviCam XS, XST, and ESView 3.0 underscores the market’s demand for non-invasive, high-resolution GI visualization. These innovations are not just advancing technology; they are setting a new standard for patient care.”

The high-traffic booth at DDW served as a launchpad for these technologies, with live demonstrations, hands-on sessions, and presentations that highlighted the precision, ease of use, and clinical impact of the new products. Attendees expressed strong interest in how these solutions can redefine both diagnostic efficiency and patient experience.

AnX Robotica remains committed to pushing the boundaries of capsule endoscopy and GI diagnostics, adding to its growing portfolio, which includes NaviCam SB with ProScan, MotiliCap, NaviCam Colon*, IntraMarX, and VibraBot.

*Colon Capsule is not available in the United States

View original content to download multimedia:https://www.prnewswire.com/news-releases/anx-robotica-unveils-navicam-xs-navicam-xst-and-esview-3-0-at-ddw-2025-to-exceptional-industry-response-302457084.html

SOURCE AnX Robotica

Staff

Recent Posts

Amazfit Introduces Balance 2 Smartwatch and Helio Strap for Smarter Training, Better Recovery and Peak Performance

Amazfit Smart Wearables Require No Additional SubscriptionMILPITAS, Calif.--(BUSINESS WIRE)--#DiscoverAmazing--Amazfit, a leading global smart wearable brand…

2 hours ago

Amazfit Introduces Balance 2 Smartwatch and Helio Strap for Smarter Training, Better Recovery and Peak Performance

Amazfit Smart Wearables Require No Additional SubscriptionMILPITAS, Calif.--(BUSINESS WIRE)--#DiscoverAmazing--Amazfit, a leading global smart wearable brand…

2 hours ago

NanoVibronix’s ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement

Dual-System Agreement Highlights Transition Towards Advanced Bedside NavigationTYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or…

2 hours ago

Candel Therapeutics Announces $15 million Registered Direct Offering of Common Stock

NEEDHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company)…

3 hours ago

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

Cincinnati Children’s Hospital Medical Center Discusses QUELIMMUNE Therapy Adoption A Father and Patient Describe Their…

3 hours ago

Innovate GBM Rings the NASDAQ Closing Bell in Honor of Brain Tumor Patients and Community

Innovate GBM Community Innovate GBM’s Community Members gather at the NASDAQ Closing Bell Ceremony—united in…

3 hours ago